Drug
Colloidal Silicon Dioxide
Colloidal Silicon Dioxide: highest development phase Phase 3, developed by Polisorb Joint Stock Company. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Polisorb Joint Stock Company
Trials
| Drug | Phase | Indication |
|---|---|---|
| Colloidal Silicon Dioxide NCT07929181 | Phase 3 | Atopic Dermatitis |
Latest
No recent events.
Follow Colloidal Silicon Dioxide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.